In the article about Difebarbamate we are going to explore in detail all the aspects related to this topic. From its origin and evolution over time, to its influence on today's society. We will analyze the different perspectives and theories related to Difebarbamate, as well as its impact in different areas, such as culture, economy, politics, technology, among others. In addition, we will address the main challenges that Difebarbamate currently faces, as well as the possible solutions and innovations that are emerging around this topic. Ultimately, this article aims to offer a complete and updated view on Difebarbamate, providing relevant information and in-depth analysis for all those interested in delving deeper into this topic.
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
ECHA InfoCard | 100.036.147 |
Chemical and physical data | |
Formula | C28H42N4O9 |
Molar mass | 578.663 g·mol−1 |
3D model (JSmol) | |
| |
|
Difebarbamate (INN) is a tranquilizer of the barbiturate and carbamate families which is used in Europe as a component of a combination drug formulation referred to as tetrabamate (Atrium, Sevrium).